Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe at... | RTCL.TV
Channel: Medicine RTCL TV
Date: 2023-12-29

### Keywords ###
#dupilumab #laboratory #safety #longterm #openlabel #clinicaltrial #RTCLTV #shorts

### Article Attribution ###
Title: Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study
Authors: Lisa A. Beck, Diamant Thaçi, Mette Deleuran, Marjolein de Bruin-Weller, Zhen Chen, Faisal A. Khokhar, Meng Zhang, Zafer E. Ozturk ,and Brad Shumel
Publisher: Taylor & Francis Group
DOI: 10.1080/09546634.2020.1871463
DOAJ URL: https://doaj.org/article/cc0f69431fbc4591a97cc99e2488a966



### Image Attribution ###
We used stable diffusion to programmatically generate the background images. 
Viewer discretion is advised.

### Channels ###
YouTube Channel: https://www.youtube.com/@medicinertcltv
Odysee Channel: https://odysee.com/@medicine_rtcl_tv

### Video Timestamps ###
0:00:00 - Summary 
0:00:22 - Title 
0:00:28 - End